Roger E. McLendon
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Genetics 183
- Glioma Diagnosis and Treatment 182
-
- Cancer Genomics and Diagnostics 37
- Co-authors
- Darell D. Bigner (124 shared papers)Jeremy N. Rich (51 shared papers)Anita B. Hjelmeland (16 shared papers)Henry S. Friedman (101 shared papers)Allan H. Friedman (71 shared papers)Shideng Bao (9 shared papers)Qiulian Wu (9 shared papers)Qing Shi (4 shared papers)
- Journals
- Neuro-Oncology (30 papers)Journal of Neuro-Oncology (21 papers)Journal of Clinical Oncology (18 papers)Cancer (16 papers)Cancer Research (14 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Roger E. McLendon
397 papers receiving 81.8k citations
Roger E. McLendon's Hit Papers
Peers
Comparison fields: 5 of 189
- Genetics 28.5k
- Cancer Research 22.5k
- Oncology 19.2k
- Molecular Biology 38.1k
- Immunology 7.7k
Countries citing papers authored by Roger E. McLendon
This map shows the geographic impact of Roger E. McLendon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger E. McLendon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger E. McLendon more than expected).
Fields of papers citing papers by Roger E. McLendon
This network shows the impact of papers produced by Roger E. McLendon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger E. McLendon. The network helps show where Roger E. McLendon may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger E. McLendon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 402 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways Hit paper breakdown → | 2008 | 6384 |
| 2 | Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Hit paper breakdown → | 2006 | 5328 |
| 3 | An Integrated Genomic Analysis of Human Glioblastoma Multiforme Hit paper breakdown → | 2008 | 4876 |
| 4 | IDH1 and IDH2 Mutations in Gliomas Hit paper breakdown → | 2009 | 4829 |
| 5 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 3977 |
| 6 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 7 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 8 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 9 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 10 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 11 | TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal Hit paper breakdown → | 2013 | 1159 |
| 12 | Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells Hit paper breakdown → | 2009 | 1135 |
| 13 | Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor Hit paper breakdown → | 2006 | 1112 |
| 14 | Altered Telomeres in Tumors with ATRX and DAXX Mutations Hit paper breakdown → | 2011 | 879 |
| 15 | The whole-genome landscape of medulloblastoma subtypes Hit paper breakdown → | 2017 | 840 |
| 16 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 17 | Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth Hit paper breakdown → | 2015 | 769 |
| 18 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 749 |
| 19 | Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth Hit paper breakdown → | 2013 | 743 |
| 20 | Subgroup-specific structural variation across 1,000 medulloblastoma genomes Hit paper breakdown → | 2012 | 731 |
About Roger E. McLendon
Roger E. McLendon is a scholar working on Genetics, Cancer Research, Oncology, Neurology and Molecular Biology, having authored 402 papers that have together received 83.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (182 papers), Cancer Genomics and Diagnostics (37 papers), Neuroblastoma Research and Treatments (34 papers), Chromatin Remodeling and Cancer (28 papers), Brain Metastases and Treatment (27 papers), Epigenetics and DNA Methylation (24 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Cancer Cells and Metastasis (22 papers). The work is most often cited by research in Genetics (28.5k citations), Cancer Research (22.5k citations), Oncology (19.2k citations), Molecular Biology (38.1k citations) and Immunology (7.7k citations). Roger E. McLendon has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Darell D. Bigner, Jeremy N. Rich, Anita B. Hjelmeland, Henry S. Friedman, Allan H. Friedman, Shideng Bao, Qiulian Wu, Qing Shi, James E. Herndon and David A. Reardon. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.